Tatva Chintan Pharma Chem’s IPO subscribed 4.51 times on Day 1

Tatva Chintan Pharma Chem’s IPO received an enthusiastic response which was subscribed to nearly 4.51 times on the first day itself.

The retail portion of the public offering was subscribed 8.25 times. The qualified Institutional Buyers (QIBs) portion was subscribed 0.51 times while the portion reserved for non-institutional investors subscribed 1.13 times.

Tatva Chintan mobilised Rs150cr of the total issue size of Rs500cr through the anchor book on July 15 at the higher end of the price band of Rs1,073-Rs1,083 per equity share.

The IPO comprises a fresh issue of Rs225cr and an offer for sale of Rs275cr by promoter and promoter group whose shareholding will be reduced to 79.2 per cent after the issue.

Tatva Chintan Pharma Chem is a specialty chemicals company manufacturing a diverse portfolio of structure-directing agents, phase transfer catalyst, electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals.

Goldman Sach, HSBC, Axis MF, Aditya Birla MF, Nippon Life AMC, SBI Life Insurance, Aberdeen, HDFC MF and Mirae Asset are some of the institutional investors that have invested in the anchor round.



#Tatva #Chintan #Pharma #Chems #IPO #subscribed #times #Day

( With inputs from indiainfoline)